Rumi Scientific Announces Partnership with X‑Chem for Development of Lead Candidate in Huntington’s Disease
NEW YORK, Dec. 05, 2023 (GLOBE NEWSWIRE) — Rumi Scientific (“Rumi”), a developer of therapies for rare and neurodegenerative diseases...
X‑Chem Announces Achievement of Collaboration Milestone
WALTHAM, Mass.; Dec. 5, 2023 (Business Wire) — X-Chem, a global leader in innovative drug discovery services, announces the achievement...
X‑Chem and Structural Genomics Consortium Enter Into Collaboration to Unlock the Human Proteome and Promote Open Science
WALTHAM, Mass.; Sept. 28, 2023 (Business Wire) – X-Chem, a global leader in innovative drug discovery services, and the Structural...
X‑Chem Appoints Chief Scientific Officer and Chief Financial Officer
WALTHAM, Mass.; Aug. 10, 2023 (Business Wire) – X-Chem, the leading provider of innovative solutions in early-stage drug discovery, announced...
X‑Chem and Kymera Expand Existing Partnership
WALTHAM, Mass.; Jan. 31, 2023 – X-Chem, the leading provider of innovative solutions in early-stage drug discovery, today announced the...
X‑Chem and Sironax Begin Neurodegenerative Disease Drug Discovery Research Partnership
WALTHAM, Mass.; Jan. 5, 2023 (Business Wire) — X-Chem (X-Chem), the global leader in DNA-encoded library (DEL) technology, today announces...